These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20177411)

  • 1. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.
    Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC
    Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
    Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
    Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.
    Zeng W; Tan AC; Horrocks K; Jackson DC
    Vaccine; 2015 Jul; 33(30):3526-32. PubMed ID: 26049002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
    Andersson AM; Håkansson KO; Jensen BA; Christensen D; Andersen P; Thomsen AR; Christensen JP
    PLoS One; 2012; 7(10):e46395. PubMed ID: 23049700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide.
    Zykova AA; Blokhina EA; Kotlyarov RY; Stepanova LA; Tsybalova LM; Kuprianov VV; Ravin NV
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33036278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    Tsybalova LM; Stepanova LA; Shuklina MA; Mardanova ES; Kotlyarov RY; Potapchuk MV; Petrov SA; Blokhina EA; Ravin NV
    PLoS One; 2018; 13(8):e0201429. PubMed ID: 30138320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).
    Mu X; Hu K; Shen M; Kong N; Fu C; Yan W; Wei A
    J Virol Methods; 2016 Feb; 228():84-90. PubMed ID: 26615805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
    Deng L; Ibañez LI; Van den Bossche V; Roose K; Youssef SA; de Bruin A; Fiers W; Saelens X
    PLoS One; 2015; 10(5):e0126650. PubMed ID: 25973787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
    El Bakkouri K; Descamps F; De Filette M; Smet A; Festjens E; Birkett A; Van Rooijen N; Verbeek S; Fiers W; Saelens X
    J Immunol; 2011 Jan; 186(2):1022-31. PubMed ID: 21169548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
    Kitikoon P; Strait EL; Thacker EL
    Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus M2e with additional cysteine residues shows enhanced immunogenicity and protection against lethal virus challenge.
    Kaminaka K; Matsuda J; Nozaki C
    Viral Immunol; 2013 Aug; 26(4):291-5. PubMed ID: 23941675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
    Hashemi H; Pouyanfard S; Bandehpour M; Noroozbabaei Z; Kazemi B; Saelens X; Mokhtari-Azad T
    PLoS One; 2012; 7(9):e45765. PubMed ID: 23029232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.
    Yong CY; Yeap SK; Ho KL; Omar AR; Tan WS
    Int J Nanomedicine; 2015; 10():2751-63. PubMed ID: 25897220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
    Lee YN; Kim MC; Lee YT; Hwang HS; Lee J; Kim C; Kang SM
    PLoS One; 2015; 10(9):e0137822. PubMed ID: 26366729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
    Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
    Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.